Juan Jesús
Cruz Hernández
Universidad de Salamanca
Salamanca, EspañaPublications in collaboration with researchers from Universidad de Salamanca (65)
2024
-
Biología celular y molecular del cáncer
Oncología clínica (Arán Ediciones), pp. 13-23
-
Diagnóstico nosológico y de extensión. Factores pronósticos
Oncología clínica (Arán Ediciones), pp. 59-71
-
Epidemiología del cáncer. Factores de riesgo y carcinogénesis
Oncología clínica (Arán Ediciones), pp. 25-42
-
Indicators to evaluate quality of care in head and neck cancer in Spain
Clinical and Translational Oncology, Vol. 26, Núm. 5, pp. 1089-1097
-
Tumores de origen desconocido
Oncología clínica (Arán Ediciones), pp. 407-418
2023
-
Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis
Chinese Clinical Oncology, Vol. 12, Núm. 6
-
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk
Cells, Vol. 12, Núm. 15
-
Multimodal Physical Exercise and Functional Rehabilitation Program in Oncological Patients with Cancer-Related Fatigue—A Randomized Clinical Trial
International Journal of Environmental Research and Public Health, Vol. 20, Núm. 6
-
Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer
International Journal of Molecular Sciences, Vol. 24, Núm. 4
2022
-
Adaptation and validation of the Spanish version of the everyday cognition battery for assessing everyday cognition in older adults
BMC Geriatrics, Vol. 22, Núm. 1
-
Cardiac magnetic resonance to detect different patterns of myocardial injury in patients receiving immune checkpoint inhibitors
Revista Espanola de Cardiologia, Vol. 75, Núm. 3, pp. 266-269
-
Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy
Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88
-
Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis
Biomedicines, Vol. 10, Núm. 2
2021
-
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis
The Lancet Oncology, Vol. 22, Núm. 5, pp. 727-736
-
Dopamine receptors and the kidney: An overview of health-and pharmacological-targeted implications
Biomolecules, Vol. 11, Núm. 2, pp. 1-16
-
Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors
Life, Vol. 11, Núm. 12
-
Impact of a comprehensive functional rehabilitation programme on the quality of life of the oncological patient with dyspnoea
Medicina Clinica, Vol. 157, Núm. 1, pp. 10-16
-
Multimodal physical exercise and functional rehabilitation program in oncological patients with asthenia. study protocol
BMC Nursing, Vol. 20, Núm. 1
-
Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies
Journal of Clinical Medicine, Vol. 10, Núm. 9
-
Specific autonomy recovery programme in a comprehensive rehabilitation on functionality and respiratory parameters in oncological patients with dyspnoea. Study protocol
BMC Nursing, Núm. 20